Memorial Sloan Kettering West Harrison (All Protocol Activities)

Running trials

• Active, not recruiting

  A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

  NCT06007937· Phase 1/2· Source

• Recruiting

  A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

  NCT05562791· Phase 1· Source

• Active, not recruiting

  Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

  NCT03504163· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting
• Melanoma1 recruiting

Researchers

No researcher is linked here yet.